BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29229610)

  • 1. Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.
    Dragomir A; Aprikian A; Kapoor A; Finelli A; Pouliot F; Rendon R; Black PC; Moore R; Breau RH; Kawakami J; Drachenberg D; Lattouf JB; Tanguay S
    CMAJ Open; 2017 Dec; 5(4):E834-E841. PubMed ID: 29229610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    Levy DA; Slaton JW; Swanson DA; Dinney CP
    J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
    Mason R; Kapoor A; Liu Z; Saarela O; Tanguay S; Jewett M; Finelli A; Lacombe L; Kawakami J; Moore R; Morash C; Black P; Rendon RA
    Urol Oncol; 2016 Nov; 34(11):486.e1-486.e7. PubMed ID: 27344410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.
    Stephenson AJ; Chetner MP; Rourke K; Gleave ME; Signaevsky M; Palmer B; Kuan J; Brock GB; Tanguay S
    J Urol; 2004 Jul; 172(1):58-62. PubMed ID: 15201737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.
    Ljungberg B; Alamdari FI; Rasmuson T; Roos G
    BJU Int; 1999 Sep; 84(4):405-11. PubMed ID: 10468753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of stage T1 renal tumours at Canadian academic centres.
    Lavallée LT; Tanguay S; Jewett MA; Wood L; Kapoor A; Rendon RA; Moore RB; Lacombe L; Kawakami J; Pautler SE; Drachenberg DE; Black PC; Lattouf JB; Morash C; Cagiannos I; Liu Z; Breau RH
    Can Urol Assoc J; 2015; 9(3-4):99-106. PubMed ID: 26085866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of two follow-up strategies for localized kidney cancer: a Canadian cohort comparison.
    Dion M; Martínez CH; Williams AK; Chalasani V; Nott L; Pautler SE
    Can Urol Assoc J; 2010 Oct; 4(5):322-6. PubMed ID: 20944802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.
    Kim EH; Vetter JM; Kuxhausen AN; Song JB; Sandhu GS; Strope SA
    Urol Oncol; 2016 May; 34(5):237.e11-8. PubMed ID: 26725251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An optimal follow-up protocol for renal cell carcinoma based on the occurrence of recurrences after surgery].
    Masatoshi M; Masatsugu I; Jun-ichiro I; Shiro B
    Nihon Hinyokika Gakkai Zasshi; 2000 Dec; 91(12):700-7. PubMed ID: 11201130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of follow-up practice of urologists across Britain and Ireland following nephrectomy for renal cell carcinoma.
    Basu S; Biyani CS; Sundaram SK; Spencer J
    Clin Radiol; 2006 Oct; 61(10):854-60; discussion 861-2. PubMed ID: 16978980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?
    Lin YK; Gettle L; Raman JD
    BJU Int; 2013 May; 111(6):891-6. PubMed ID: 23331317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical nephrectomy for renal cell carcinoma. Report 1. Analysis according to the TNM staging system of the general rule for clinical and pathological studies on renal cell carcinoma].
    Nishio Y; Nishimura K; Hida S; Okada Y; Takeuchi H; Miyakawa M; Okada K; Yoshida O
    Hinyokika Kiyo; 1987 Mar; 33(3):337-43. PubMed ID: 3618401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma.
    Zielinski H; Szmigielski S; Petrovich Z
    Am J Clin Oncol; 2000 Feb; 23(1):6-12. PubMed ID: 10683065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
    Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A generation of laparoscopic nephrectomy: stage-specific surgical and oncologic outcomes for laparoscopic nephrectomy in a single center.
    Laird A; Stewart GD; Zhong J; Ang WJ; Cutress ML; Riddick AC; McNeill SA; Tolley DA
    J Endourol; 2013 Aug; 27(8):1008-14. PubMed ID: 23634886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
    Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Usage of Different Guidelines in Routine Management, Therapy and Follow-Up of Patients with Renal Cell Cancer in Germany.
    Spek A; Szabados B; Ziegelmüller B; Stief C; D'Anastasi M; Staehler M
    Urol Int; 2017; 98(2):156-161. PubMed ID: 27750248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.